Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Odds ratio (95% CI) | P value | Odds ratio (95% CI) | P value | |
Age | 0.99 (0.95–1.02) | 0.41 | ||
RA duration | 1.00 (0.99–1.00) | 0.37 | ||
MTX dose | 1.07 (0.94–1.238) | 0.30 | ||
DAS28(ESR) | 0.50 (0.31–0.75) | <0.001 | 0.67 (0.40–1.06) | 0.09 |
HAQ-DI | 0.69 (0.36–1.29) | 0.25 | ||
EQ-5D | 41.89 (1.88–1496.64) | 0.02 | 1.66 (0.01–287.19) | 0.83 |
CRP | 0.88 (0.73–1.03) | 0.12 | ||
RF | 1.00 (0.99–1.00) | 0.50 | ||
ACPA | 1.00 (0.99–1.00) | 0.30 | ||
MMP-3 | 1.00 (0.99–1.00) | 0.69 | ||
TNFα | 1.18 (0.98–1.72) | 0.09 | ||
IL-6 | 1.00 (0.99–1.01) | 0.46 | ||
HAQ-DI at 24 h | 0.53 (0.25–1.04) | 0.07 | ||
EQ-5D at 24 h | 123.61 (4.82–5356.39) | <0.001 | 26.33 (0.514–7838.05) | 0.09 |
CRP at 24 h | 0.85 (0.66–1.02) | 0.08 | ||
CRP at 48 h | 0.77 (0.53–1.02) | 0.07 | ||
TNFα at 24 h | 0.20 (0.05–0.55) | <0.001 | 0.01 (0.04e−2–0.22) | <0.01 |
TNFα at 48 h | 0.01 (2.636e-5–0.54) | <0.001 | 9.26 (0.30–342.47) | 0.20 |
IL-6 at 24 h | 0.98 (0.95–0.99) | 0.03 | 1.00 (0.97–1.01) | 0.92 |
IL-6 at 48 h | 0.04 (0.01–0.60) | 0.02 | 0.97 (0.92–1.03) | 0.27 |
CZP at 24 h | 15.56 (1.95–154.84) | <0.001 | 1.00 (0.99–1.01) | 0.33 |
CZP at 48 h | 16.76 (1.82–190.40) | 0.01 | 1.00 (0.99–1.01) | 0.24 |